Laboratory Corporation of America has invested $2 million in SynapDx. The Lexington, Mass.-based company will use the funding to develop a blood-based assay that can diagnose autism spectrum disorder in children earlier than existing tests.
Mass. diagnostics company gets $2M boost for autism assay
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||